One more death was reported from dengue in 24 hours till Sunday morning, raising the number of fatalities from the ...

India's DengiAll vaccine trial is nearing completion. ICMR scientists anticipate enrolling 10,500 participants by October ...

The enrolment for phase III clinical trials of India's first dengue vaccine, DengiAll, is expected to be completed by October ...

The new WHO guidelines offer evidence-based protocols for managing dengue, chikungunya, Zika and yellow fever, aiming to ...

Health authorities in HCM City have issued an urgent alert after six people died from dengue fever, amid a spike in ...

Dengue, an Aedes mosquito-borne viral infection, has been a crucial public health concern during the monsoon in our country ...

ICMR and Panacea Biotec conduct third phase trials for indigenous dengue vaccine in India with promising results.

WHO has issued guidelines to tackle the arbovirus diseases, which continue to be a major threat to life. Read on to know it ...

The phase III clinical trial enrolment for India's first one-shot dengue vaccine, DengiAll, developed by Panacea Biotec, is set to complete with 10,500 participants across 20 centers. This trial aims ...

The one-shot vaccine, developed by Panacea Biotec and branded as DengiAll, is being tested through a multi-centre, ...

Phase-III trial of indigenous one-shot dengue vaccine by Panacea Biotec shows promising results in India, aiming for completion by October.